✦ LIBER ✦

Malignant lymphoma supervening in chronic lymphocytic leukemia and related disorders. Richter's syndrome: A study of 25 cases

✍ Scribed by J. L. Harousseau; G. Flandrin; G. Tricot; J. C. Brouet; M. Seligmann; Jean Bernard

Publisher: John Wiley and Sons
Year: 1981
Tongue: English
Weight: 811 KB
Volume: 48
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19810915)48:6<1302::aid-cncr2820480609>3.0.co;2-q

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A study of allergy in patients with mali

A study of allergy in patients with malignant lymphoma and chronic lymphocytic leukemia

✍ David P. McCormick; Arthur J. Ammann; Kimishige Ishizaka; Daniel G. Miller; Rich 📂 Article 📅 1971 🏛 John Wiley and Sons 🌐 English ⚖ 534 KB

Relationship between chronic lymphocytic

Relationship between chronic lymphocytic leukemia and small lymphocytic lymphoma. A comparative study of membrane phenotypes in 270 cases

✍ Al Batata; Bo Shen 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 865 KB

Primary central nervous system lymphoma

Primary central nervous system lymphoma as a variant of Richter's syndrome in two patients with chronic lymphocytic leukemia

✍ Brin P. O'neill; Thomas M. Habermann; Peter M. Banks; Judith R. O'Fallon; John D 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 742 KB

Tumor lysis syndrome occurring after the

Tumor lysis syndrome occurring after the administration of rituximab in lymphoproliferative disorders: High-grade non-Hodgkin's lymphoma and chronic lymphocytic leukemia

✍ Yang, Honghao; Rosove, Michael H.; Figlin, Robert A. 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 27 KB 👁 2 views

Rituximab, an anti-CD20 antibody, has been recently approved for the treatment of lowgrade or follicular non-Hodgkin's lymphoma (NHL). Because of its relatively benign side effect profile, it has been considered a nontoxic alternative to chemotherapy. Recently, however, tumor lysis syndrome (TLS) re